Abstract | UNLABELLED: METHODS: RESULTS:
Tumor uptake of (89)Zr-AMG 110 can be clearly visualized using small-animal PET imaging up to 72 h after injection. The highest tumor uptake of (89)Zr-AMG 110 at the 40-μg dose level was observed at 6 and 24 h (respectively, 5.35 ± 0.22 and 5.30 ± 0.20 percentage injected dose per gram; n = 3 and 4). Tumor uptake of (89)Zr-AMG 110 was EpCAM-specific and correlated with EpCAM expression. 800CW-AMG 110 accumulated at the tumor cell surface in viable EpCAM-expressing tumor tissue. CONCLUSION: PET and fluorescent imaging provided real-time information about AMG 110 distribution and tumor uptake in vivo. Our data support using (89)Zr and IRDye 800CW to evaluate tumor and tissue uptake kinetics of bispecific T cell engager antibody constructs in preclinical and clinical settings.
|
Authors | Frank J Warnders, Stijn J H Waaijer, Martin Pool, Marjolijn N Lub-de Hooge, Matthias Friedrich, Anton G T Terwisscha van Scheltinga, Petra Deegen, Sabine K Stienen, Peter C Pieslor, H Kam Cheung, Jos G W Kosterink, Elisabeth G E de Vries |
Journal | Journal of nuclear medicine : official publication, Society of Nuclear Medicine
(J Nucl Med)
Vol. 57
Issue 5
Pg. 812-7
(05 2016)
ISSN: 1535-5667 [Electronic] United States |
PMID | 26848172
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc. |
Chemical References |
- Antibodies, Monoclonal
- Epithelial Cell Adhesion Molecule
- Radioisotopes
- Zirconium
|
Topics |
- Animals
- Antibodies, Monoclonal
(immunology, pharmacokinetics)
- Epithelial Cell Adhesion Molecule
(immunology)
- HL-60 Cells
- HT29 Cells
- Humans
- Isotope Labeling
- Male
- Mice
- Positron-Emission Tomography
(methods)
- Radioisotopes
- T-Lymphocytes
(immunology)
- Tissue Distribution
- Zirconium
|